Thermo Fisher Scientific Inc (TMO)

Nov 3, 2026

Waters Corporation (NYSE: WAT) stock rose after reporting better-than-expected third-quarter results, raising its full-year outlook, and announcing the acquisition of MOBILion Systems Inc. The company's growth was driven by strong demand for laboratory instruments and consumables, especially fueled by GLP-1 drug testing and a recovery in its China Biosciences business. CEO Udit Batra highlighted that AI is already increasing demand for Waters' instruments as drugmakers accelerate research and development.

Nov 2, 2026

Bruker (NASDAQ: BRKR), a scientific instrument company, is set to report its Q3 earnings this Wednesday morning. Analysts expect the company's revenue to be flat year-on-year, and while peers Avantor and Thermo Fisher beat revenue expectations, their stock prices fell. Bruker's stock is down 12.8% over the last month, heading into earnings with an average analyst price target higher than its current share price.

Nov 2, 2026

Thermo Fisher Scientific (NYSE: TMO) has significantly outperformed the market over the past decade, achieving an average annual return of 16.17%. An initial investment of $100 in TMO stock 10 years ago would now be valued at $449.67. This demonstrates the substantial impact of compounded returns on wealth growth over time.

Nov 2, 2026

This article examines the hypothetical return on a $1000 investment in Thermo Fisher Scientific (TMO) made ten years ago. It details the company's business segments, recent acquisitions, and financial performance, concluding that such an investment would be worth $4,734.73 today, a 373.47% gain, outperforming the S&P 500 and gold. The article also provides an analyst outlook on TMO, noting both growth drivers and risks.

Oct 29, 2026

As of Wednesday, October 28, 2026, 19 S&P 500 stocks were trading at their 52-week highs, with Thermo Fisher Scientific leading the list in market value. The Health Care sector contributed the most names, accounting for 12 of the 19 companies. The article provides a table of the top 10 largest companies by market cap, along with their returns over various periods, and discusses the underlying business metrics for some of the biggest new highs.

Oct 28, 2026

Shares of Thermo Fisher Scientific Inc. (TMO) rose 1.61% to $704.15 on Wednesday, outperforming the broader market. This marks the stock's third consecutive day of gains, occurring during a positive trading session where the S&P 500 Index and Dow Jones Industrial Average also saw increases.

Oct 28, 2026

Evercore ISI has adjusted its price target for Thermo Fisher Scientific (TMO) from $720 to $615. Despite this adjustment, the company maintains an average "overweight" rating with a mean price target of $741.79. Full details of this report are available to Yahoo Finance Plus Silver subscribers.

Oct 28, 2026

Several companies including ACT Energy Technologies, Amgen, and Bausch + Lomb Corporation reached 52-week highs following various company news. Amgen declared a quarterly dividend, Bausch + Lomb reported stronger-than-expected earnings, and other firms like CES Energy Solutions and Precision Drilling announced upcoming financial results or business updates. The article also highlights the performance of The Toronto-Dominion Bank and Thermo Fisher Scientific, which also hit 52-week highs.

Oct 27, 2026

Shares of Thermo Fisher Scientific Inc. (TMO) rose 1.19% to $693.02 on Tuesday, outperforming the broader market which also saw gains, with the S&P 500 Index rising 0.60% and the Dow Jones Industrial Average rising 0.03%. This marked the second consecutive day of gains for the stock.

Oct 27, 2026

Argus has lowered its rating for Bio-Techne Corporation (TECH) to SELL, citing the company's development and marketing of protein-based instruments and reagents for research and clinical use. The company serves pharmaceutical and biotech industries, as well as academic institutions. The current price is $72.69.